The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic validation of a digital pathology-based multi-modal artificial intelligence (MMAI) biomarker in patients with metastatic hormone-sensitive prostate cancer (mHSPC) from the CHAARTED trial (ECOG-ACRIN EA3805).
 
Mark Christopher Markowski
No Relationships to Disclose
 
Yi Ren
Employment - Artera, INC.
Stock and Other Ownership Interests - Artera, INC.
 
Danielle Croucher
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Trevor Joseph Royce
Employment - ArteraAI; Flatiron Health
Stock and Other Ownership Interests - Lumata Health; mPATH; Roche; SonoVascular; VitriVax
Consulting or Advisory Role - Agilix Health
 
Rikiya Yamashita
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Meghan Tierney
Employment - Artera; PicnicHealth
Stock and Other Ownership Interests - Artera; PicnicHealth
 
Huei-Chung Huang
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Tamara Todorovic
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Emmalyn Chen
Employment - Artera, Inc.
Stock and Other Ownership Interests - Artera, Inc.
 
Michael Anthony Carducci
Honoraria - Remedica
Consulting or Advisory Role - Acrivon Therapeutics; AstraZeneca; Pfizer; Sanofi
Research Funding - Arcus Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Merck (Inst); pfizer (Inst)
 
Yu-Hui Chen
Employment - Ribonaut Therapeutics (I); Ribonaut Therapeutics (I)
 
Glenn Liu
Employment - AIQ Solutions
Leadership - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Consulting or Advisory Role - Janssen medical Affairs
Research Funding - Johnson & Johnson (Inst); Madison Vaccines, Inc.; Novartis (Inst); Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
 
Charles Parker
Research Funding - Artera (Inst)
Other Relationship - Artera (Inst)
 
Andre Esteva
Employment - Artera
Leadership - Artera
Stock and Other Ownership Interests - Artera
Patents, Royalties, Other Intellectual Property - Artera's founding IP - multi-modal AI technology for cancer therapy personalization, using digital pathology.
Travel, Accommodations, Expenses - Artera
 
Felix Y Feng
Stock and Other Ownership Interests - Artera; ClearNote Health; Serimmune
Consulting or Advisory Role - Artera; Bayer; Bristol-Myers Squibb; ClearNote Health; Exact Sciences; Foundation Medicine; Janssen Oncology; Novartis; Serimmune; Tempus; Varian Medical Systems
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen; Janssen (I)
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; AstraZeneca; Bayer; ESSA; Ferring; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Astellas Pharma (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Ferring; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems
Other Relationship - Institute of Cancer Research
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Cadence Pharma; CellCentric; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; POINT Biopharma
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination